FDA approved Lundbeck’s VYEPTI™ – the first and only intravenous preventive treatment for migraine
On Feb. 21, 2020, Lundbeck announced that VYEPTI™ (eptinezumab-jjmr) had been approved by the U.S. Food and Drug…
On Feb. 21, 2020, Lundbeck announced that VYEPTI™ (eptinezumab-jjmr) had been approved by the U.S. Food and Drug…
On Feb. 21, 2020, the U.S. Food and Drug Administration (FDA) approved NEXLETOL (bempedoic acid) tablet, an oral,…
On Feb. 21, 2020, a $2 million gift from University of Missouri alumni will support the university’s NextGen…
On Feb. 21, 2020, the U.S. Food and Drug Administration (FDA) authorized marketing of the first test to…
On Feb. 24, 2020, researchers reported that the spikes crowning the new coronavirus that causes COVID-19 atypical pneumonia…
On Feb. 20, 2020, using a machine-learning algorithm, researchers at MIT and the Broad Institute of MIT and…
On Feb. 20, 2020, Tim Boyle, CEO of Columbia Sportswear, and his wife, Mary, made a $10 million…
On Feb. 19, 2020, NIAID scientists working with investigators from the University of Texas at Austin identified the…
On Feb. 19, 2020, Cancer Prevention & Research Institute of Texas (CPRIT) announced it had awarded 55 grants…
On Feb. 18, 2020, Sanofi announced it had leveraged previous development work for a SARS vaccine which may…
On Feb. 18, 2020, Innovation Pharma announced the Company was exploring its lead defensin mimetic drug candidate, Brilacidin,…
On Feb. 16, 2020, Medigen Vaccine Biologics (MVB) and the National Institutes of Health (NIH) announced they had…
On Feb. 13, 2020, a study published in Cell provided an unprecedented look at the dozens of molecular…
On Feb. 13, 2020, National Institutes of Health (NIH) scientists announced that the experimental antiviral remdesivir successfully prevented…
On Feb. 12, 2020, leading health experts from around the world met at the World Health Organization’s (WHO)…
On Feb. 12, 2020, Vir Biotech announced it had identified two monoclonal antibodies (mAbs) that bind to SARS-CoV-2…
On Feb. 12, 2020, Chembio Diagnostics announced a $1.5 million purchase order from UNICEF for multiplex Zika tests…
On Feb. 10, 2020, the World Health Organization (WHO) and the Foundation for Innovative New Diagnostics (FIND) announced…
On Feb. 7, 2020, two University of Nebraska Medical Center faculty members are among a group of researchers…
On Feb. 5, 2020, The Pan-cancer analysis of whole genomes was published in Nature. The flagship paper of…
On Feb. 5, 2020, to fight further spread of the new coronavirus (2019-nCoV) outbreak in China and globally,…
On Feb. 5, 2020, an international team announced that it had completed the most comprehensive study of whole…
On Feb. 4, 2020, BioMotiv and Bristol-Myers Squibb announced the launch of Anteros Pharmaceuticals, a biotechnology company focused…
On Feb. 4, 2020, the Fred Hutchinson Cancer Research Center announced that a promising HIV vaccine trial was…
On Feb. 3, 2020, CEPI, the Coalition for Epidemic Preparedness Innovations, and GSK announced a new collaboration aimed…
On Feb. 3, 2020, the CDC released the 2020 recommended immunization schedules for children and adolescents, as well…
On Jan. 31, 2020, Mammoth Biosciences announced the company had received a contract from the National Institutes of…
On Jan. 31, 2020, Vaxart announced it had initiated a program to develop a coronavirus vaccine candidate based…
On Jan 31, 2020, Taconic Biosciences announced that it had expanded its immuno-oncology portfolio with the launch of…
On Jan. 31, 2020, the U.S. Departments of Health and Human Services announced that as a result of…